Resources

In this Exclusive Interview, Laura Shane-McWhorter talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about nutritional products in the treatment of cardiovascular disease and diabetes.

In part 1 of this Exclusive Interview, Laura Shane-McWhorter talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about the variety of supplements that exist for weight loss and the importance of understanding the patient experience with these products.

In part 2 of this Exclusive Interview, Laura Shane-McWhorter talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about determining the quality of supplements and where to get them.

In part 3 of this Exclusive Interview, Laura Shane-McWhorter talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about her product recommendations to help with weight loss, which should always be in conjunction with proper diet and exercise, not in place of.

In part 4 of this Exclusive Interview, Laura Shane-McWhorter talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about the regulation of supplements and the potential dangers of some products.

In part 5, the conclusion of this Exclusive Interview, Laura Shane-McWhorter talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about the possibilities of creating a supplement product and the references that can help health care providers to ferret out the best products to recommend.

Multi-center study compares closed-loop device to standard open-loop system in a home setting.

Restoring Insulin Secretion (RISE) Pediatric Medication Study shows that youth have markedly reduced insulin sensitivity and respond differently to medications.

Analysis of European Steno 2 study examines long-term economic implications of interventions targeting complications.

Hybrid closed-loop (HCL) system combines technology of CGM and insulin pumps, and a personalized, model-predictive control algorithm to deliver insulin day and night.